Parkinson's Today Blog

PD and Medication: Advancing Treatment

Date
Author
Parkinson's Foundation

The second most common neurodegenerative disorder after Alzheimer’s disease, Parkinson’s disease (PD) affects approximately one million Americans. Scientists are working toward discoveries to prevent or slow the disease early on, before it affects movement. Breakthrough studies include genetic research that could lead to targeted PD therapy.

Category
Research Round Up

Isradipine Study Results Disappointing

Date
Author
Parkinson's Foundation

The prevalence of Parkinson’s disease (PD) is expected to double in the next 20 years. To date, there are no proven strategies for slowing the progression of PD. A calcium channel blocker medication used to treat hypertension called, Isradipine, has been shown to be neuroprotective in animal models of PD. Several studies of people also indicated the possibility that taking Isradipine may reduce the risk for PD.

Category
Science News

How an Innovative Research Center Studies the Gut–Brain Connection

Date
Author
Parkinson's Foundation

“Parkinson’s disease (PD) is not only happening in the brain,” said Malú Tansey, PhD, Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida (UF), a Parkinson’s Foundation Center of Excellence. “It’s a multisystem disease with many non-motor symptoms that manifest in the gastrointestinal system.”

Category
Research Round Up

15 Practical Ways to Plan for Parkinson’s From Home

Date
Author
Parkinson's Foundation

As the coronavirus pandemic evolves, we stay committed to providing you with the latest updates and ways you can stay engaged with the Parkinson’s community. Even though COVID-19 plays a role in our daily lives this month, April is still Parkinson’s Awareness Month and the Parkinson’s Foundation remains dedicated to bringing light to the prevalence of Parkinson’s.

Category
Raise Awareness

mail icon

Subscribe here to get the latest news on treatments, research and other updates.